ultrathin-strut vs thin-strut DES vs DEB in treating DES restenosis; TAILORED-CHIP trial design examining time-based antiplatelet therapy in high-risk PCIs; and more
The management of concomitant coronary artery disease (CAD) in patients undergoing transcatheter aortic valve implantation (TAVI) remains a debated issue, weighing the potential prognostic benefits of treating CAD against the procedural risks and uncertain outcomes.
In patients with high-risk non-ST-elevation acute coronary syndrome, FFR-CT has superior diagnostic performance compared to CCTA alone in ruling out significant coronary artery disease and reducing unnecessary invasive procedures.
The EuroIntervention team and Editors will be present at TCT 2024 in Washington from October 27-30. Don’t miss the latest updates from the journal during the event.
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)